3 Best Marijuana Stocks to Buy Today! Trump will Reschedule Medical Marijuana.
🚀 Marijuana Rescheduling: Best Cannabis Stocks to Buy Now & Economic Impact
The cannabis industry is at a major turning point. With the Trump administration actively considering rescheduling marijuana from a Schedule I drug to Schedule III, the financial markets and U.S. economy could see sweeping changes. This YouTube video explores the effects of rescheduling, the best marijuana stocks to buy now, and why this decision could have a positive impact on the economy in both the short and long term.
If you’re an investor, entrepreneur, or simply curious about the future of the cannabis market, this deep dive will give you the insights you need.
🌿 What Does Marijuana Rescheduling Mean?
Currently, cannabis is a Schedule I substance under federal law, alongside drugs like heroin. This classification has prevented legitimate cannabis companies from operating like normal businesses. They face unique tax burdens, lack access to traditional banking, and remain in legal limbo at the federal level—even while most states allow either medical or recreational use.
By rescheduling cannabis to Schedule III, the government would finally acknowledge its medical uses and reduce restrictions. This wouldn’t be full legalization, but it would be the biggest step forward in decades.
Effects of Rescheduling Include:
Elimination of Section 280E tax restrictions, allowing cannabis companies to deduct ordinary business expenses like every other industry.
Increased profit margins for U.S. multi-state operators (MSOs).
📈 Best Marijuana Stocks to Buy Before Rescheduling
Here are the top three cannabis stocks to watch:
1. Green Thumb Industries (GTBIF)
One of the few profitable U.S. operators.
Operates over 100 dispensaries across key states.
Strong fundamentals mean it could see sustained gains when 280E tax relief kicks in.
Short-term upside: 20–30% rally immediately after rescheduling.
Long-term upside: Better positioned for institutional adoption and Wall Street coverage.
2. Tilray Brands (TLRY)
Popular among retail investors with a history of explosive rallies.
Extremely high short interest, making it a top candidate for a short squeeze.
Short-term upside: Could double in the days following rescheduling news.
Long-term upside: If momentum holds, could climb to $3–4 or higher from current $1 levels.
3. Canopy Growth (CGC)
Once the biggest cannabis stock in the world, now heavily shorted.
Strong U.S. expansion strategy with Acreage and other acquisitions.
Like Tilray, it benefits from massive retail attention and speculative momentum.
Short-term upside: Potential rally to $2.00–2.50 immediately after news.
Long-term upside: Could push $3–4 if the squeeze intensifies.
Other names to watch: Curaleaf (CURLF), Trulieve (TCNNF), Aurora (ACB), and SNDL. But in terms of the best balance between speculative upside and fundamental strength, GTBIF, TLRY, and CGC are the leaders.
💡 Positive Impact on the U.S. Economy
Beyond stock market opportunities, marijuana rescheduling could have massive benefits for the economy:
Tax Revenue Growth
Legal cannabis already generates billions in state taxes.
Federal recognition would expand tax revenue streams nationwide.
Job Creation
The cannabis sector already supports over 400,000 U.S. jobs.
Rescheduling would accelerate hiring in farming, retail, logistics, and ancillary industries.
Banking & Financial Services Expansion
Cannabis companies would gain access to mainstream banking, loans, and credit facilities.
This would fuel growth, mergers, and acquisitions—further stimulating the economy.
🔥 Why This Could Trigger Short Squeezes
Stocks like Tilray (TLRY) and Canopy Growth (CGC) have high short interest, meaning many investors are betting against them. If rescheduling passes, shorts could be forced to cover, creating massive buying pressure. This is exactly the setup that fueled previous meme stock rallies like AMC and GameStop.
Marijuana rescheduling represents one of the biggest catalysts in cannabis history. Whether you’re looking for short-term plays like TLRY and CGC or long-term winners like GTBIF, this is a moment investors have been waiting for.
The decision would not only lift cannabis stocks, but also:
Stimulate the U.S. economy.
Create jobs.
Unlock banking and capital access.
Provide new tax revenues for states and the federal government.
marijuana rescheduling, cannabis stocks 2025, best marijuana stocks to buy now, Tilray stock, Canopy Growth stock, Green Thumb Industries stock, GTBIF stock, TLRY short squeeze, CGC short squeeze, Trump marijuana news, cannabis investing 2025, marijuana legalization news, Section 280E repeal, cannabis economy, cannabis jobs, cannabis stock rally, marijuana reclassification
